FRESENIUS MEDICAL CAREFRESENIUS MEDICAL CAREFRESENIUS MEDICAL CARE

FRESENIUS MEDICAL CARE

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪12.16 B‬EUR
2.25EUR
‪499.00 M‬EUR
‪19.45 B‬EUR
‪199.03 M‬
Beta (1Y)
0.68
Employees (FY)
‪119.84 K‬
Change (1Y)
‪−8.2 K‬ −6.40%
Revenue / Employee (1Y)
‪179.17 K‬EUR
Net income / Employee (1Y)
‪4.60 K‬EUR

About FRESEN.MED.CARE KGAA O.N.


CEO
Helen Giza
Headquarters
Bad Homburg
Founded
2006
ISIN
DE0005785802
FIGI
BBG00HLJD529
Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcare products business including research and development, manufacturing, supply chain, and commercial operations as well as supporting functions, such as regulatory and quality management. The Care Delivery segment focuses on the health care services for the treatment of CKD, ESRD, and other extracorporeal therapies, including value and risk-based care programs. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
F
USU3149FAB5
FRES.MED.III 20/31 REGS
Yield to maturity
6.61%
Maturity date
Feb 16, 2031
F
FMS5184425
Fresenius Medical Care US Finance III, Inc. 3.0% 01-DEC-2031
Yield to maturity
6.33%
Maturity date
Dec 1, 2031
F
US35805BAA61
FreMedCarUSFin3 3,75% 15/06/2029 Rule 144A
Yield to maturity
5.55%
Maturity date
Jun 15, 2029
F
USU3149FAA76
FreMedCarUSFin3 3,75% 15/06/2029 Reg S
Yield to maturity
5.17%
Maturity date
Jun 15, 2029
FMEE
FRESE.MED.CARE MTN 20/30
Yield to maturity
3.50%
Maturity date
May 29, 2030
XS2084488209
FreseniusMedCar 1,25% 29/11/2029
Yield to maturity
3.17%
Maturity date
Nov 29, 2029
XS253044462
FRESE.MED.CARE MTN 22/27
Yield to maturity
2.91%
Maturity date
Sep 20, 2027
XS208449770
FRESE.MED.CARE MTN 19/26
Yield to maturity
2.82%
Maturity date
Nov 30, 2026
FMED
FRESE.MED.CARE MTN 20/26
Yield to maturity
2.77%
Maturity date
May 29, 2026
XS185453294
FRESE.MED.CARE MTN 18/25
Yield to maturity
2.74%
Maturity date
Jul 11, 2025

Explore more bonds 

Frequently Asked Questions


The current price of 4FME is 42.34 EUR — it has increased by 0.85% in the past 24 hours. Watch FRESENIUS MEDICAL CARE stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EUROTLX exchange FRESENIUS MEDICAL CARE stocks are traded under the ticker 4FME.
4FME stock has risen by 1.37% compared to the previous week, the month change is a 5.89% rise, over the last year FRESENIUS MEDICAL CARE has showed a 16.99% increase.
We've gathered analysts' opinions on FRESENIUS MEDICAL CARE future price: according to them, 4FME price has a max estimate of 52.00 EUR and a min estimate of 29.00 EUR. Watch 4FME chart and read a more detailed FRESENIUS MEDICAL CARE stock forecast: see what analysts think of FRESENIUS MEDICAL CARE and suggest that you do with its stocks.
4FME reached its all-time high on Feb 1, 2018 with the price of 93.68 EUR, and its all-time low was 26.53 EUR and was reached on Oct 28, 2022. View more price dynamics on 4FME chart.
See other stocks reaching their highest and lowest prices.
4FME stock is 2.31% volatile and has beta coefficient of 0.68. Track FRESENIUS MEDICAL CARE stock price on the chart and check out the list of the most volatile stocks — is FRESENIUS MEDICAL CARE there?
Today FRESENIUS MEDICAL CARE has the market capitalization of ‪12.16 B‬, it has decreased by −0.79% over the last week.
Yes, you can track FRESENIUS MEDICAL CARE financials in yearly and quarterly reports right on TradingView.
FRESENIUS MEDICAL CARE is going to release the next earnings report on Feb 25, 2025. Keep track of upcoming events with our Earnings Calendar.
4FME earnings for the last quarter are 0.82 EUR per share, whereas the estimation was 0.71 EUR resulting in a 15.40% surprise. The estimated earnings for the next quarter are 0.88 EUR per share. See more details about FRESENIUS MEDICAL CARE earnings.
FRESENIUS MEDICAL CARE revenue for the last quarter amounts to ‪4.82 B‬ EUR, despite the estimated figure of ‪4.95 B‬ EUR. In the next quarter, revenue is expected to reach ‪5.47 B‬ EUR.
4FME net income for the last quarter is ‪213.03 M‬ EUR, while the quarter before that showed ‪187.03 M‬ EUR of net income which accounts for 13.90% change. Track more FRESENIUS MEDICAL CARE financial stats to get the full picture.
Yes, 4FME dividends are paid annually. The last dividend per share was 1.19 EUR. As of today, Dividend Yield (TTM)% is 2.87%. Tracking FRESENIUS MEDICAL CARE dividends might help you take more informed decisions.
FRESENIUS MEDICAL CARE dividend yield was 3.13% in 2023, and payout ratio reached 69.97%. The year before the numbers were 3.66% and 48.77% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 23, 2024, the company has ‪119.84 K‬ employees. See our rating of the largest employees — is FRESENIUS MEDICAL CARE on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. FRESENIUS MEDICAL CARE EBITDA is ‪3.18 B‬ EUR, and current EBITDA margin is 16.45%. See more stats in FRESENIUS MEDICAL CARE financial statements.
Like other stocks, 4FME shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade FRESENIUS MEDICAL CARE stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So FRESENIUS MEDICAL CARE technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating FRESENIUS MEDICAL CARE stock shows the buy signal. See more of FRESENIUS MEDICAL CARE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.